Craig Eagle
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
- Pharmacology 14
- Inflammatory mediators and NSAID effects 14
- Oncology 7
- Colorectal Cancer Treatments and Studies 3
- Global Cancer Incidence and Screening 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Ann G. Zauber (8 shared papers)Nadir Arber (6 shared papers)Bernard Levin (6 shared papers)Janet Wittes (3 shared papers)Scott D. Solomon (3 shared papers)Paola Gerletti (3 shared papers)I Rácz (3 shared papers)Julius Špičák (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Gastroenterology (4 papers)Cancer Prevention Research (3 papers)The American Journal of Gastroenterology (2 papers)Circulation (2 papers)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
Craig Eagle
25 papers receiving 1.6k citations
Craig Eagle's Hit Papers
Peers
Comparison fields: 5 of 94
- Pharmacology 655
- Cancer Research 259
- Oncology 444
- Biochemistry 103
- Pathology and Forensic Medicine 182
Countries citing papers authored by Craig Eagle
This map shows the geographic impact of Craig Eagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Eagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Eagle more than expected).
Fields of papers citing papers by Craig Eagle
This network shows the impact of papers produced by Craig Eagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Eagle. The network helps show where Craig Eagle may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig Eagle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Celecoxib for the Prevention of Colorectal Adenomatous Polyps Hit paper breakdown → | 2006 | 755 |
| 2 | A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening Hit paper breakdown → | 2024 | 217 |
| 3 | 2006 | 206 | |
| 4 | 2006 | 90 | |
| 5 | 2010 | 59 | |
| 6 | 2011 | 59 | |
| 7 | 2008 | 46 | |
| 8 | 2011 | 42 | |
| 9 | 2009 | 41 | |
| 10 | 2001 | 39 | |
| 11 | 2010 | 28 | |
| 12 | 2000 | 16 | |
| 13 | 2011 | 14 | |
| 14 | 2023 | 6 | |
| 15 | 2012 | 5 | |
| 16 | 2023 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2008 | 1 |
About Craig Eagle
Craig Eagle is a scholar working on Pharmacology, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (14 papers), Cancer, Lipids, and Metabolism (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Global Cancer Incidence and Screening (2 papers), Genetic factors in colorectal cancer (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Pharmacology (655 citations), Cancer Research (259 citations), Oncology (444 citations), Biochemistry (103 citations) and Pathology and Forensic Medicine (182 citations). Craig Eagle has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Ann G. Zauber, Nadir Arber, Bernard Levin, Janet Wittes, Scott D. Solomon, Paola Gerletti, I Rácz, Julius Špičák, Miroslav Zavoral and María José Lechuga. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology, Cancer Prevention Research, The American Journal of Gastroenterology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.